Bcl-2 Expression in Target Cells Leads to Functional Inhibition of Caspase-3 Protease Family in Human NK and Lymphokine-Activated Killer Cell Granule-Mediated Apoptosis

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 126-134

  Renvoizé, Claire ^a   Roger, Rémi ^a   Moulian, Nathalie ^a,b   Bertoglio, Jacques ^a   Bréard, Jacqueline ^a  

^a INSERM   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CYSTEINE PROTEINASE; GRANZYME; GZMB PROTEIN, HUMAN; PROTEIN BCL 2; SERINE PROTEINASE;

APOPTOSIS; ARTICLE; CELL GRANULE; CELL LINE; DRUG EFFECT; EXOCYTOSIS; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PATHOLOGY;

APOPTOSIS; CASPASE 3; CASPASES; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYTOPLASMIC GRANULES; EXOCYTOSIS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GRANZYMES; HUMANS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SERINE ENDOPEPTIDASES;

EID: 0031178835     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Russell, J. H., and C. B. Dobos. 1980. CTL-induced nuclear disintegration of the target begins within minutes of cell contact. J. Immunol. 125:1256.
2. Henkart P. A., M. P. Hayes, and J. W. Shiver. 1993. The granule exocytosis model for lymphocyte cytotoxicity and its relevance to target cell DNA break-down. In Cytotoxic Cells. M. Sitkowsky and P. A. Henkart, eds. Birkhäuser, Boston, MA, p. 153.
3. Shresta, S., J. W. Heusel, D. M. McIvor, R. L. Wesselschmidt, J. H. Russell, and T. J. Ley. 1995. Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis. Immunol. Rev. 146:211.
4. Alnemri, E. S., D. J. Livingston, D. W. Nicholson, G. Salvesen, N. A. Thornberry, W. W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell 87:171.
5. Henkart, P. A. 1996. ICE family proteases: mediators of all apoptotic cell death? Immunity 4:195.
6. Patel, T., G. J. Gores, and S. H. Kaufmann. 1996. The role of proteases during apoptosis. FASEB J. 10:587.
7. Nicholson, D. W. 1996, ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol. 14:297.
8. Darmon, A. J., D. W. Nicholson, and R. C. Bleackley. 1995. Activation of the apoptotic protease CPP-32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446.
9. Martin, S. J., G. P. Amarante-Mendes, L. Shi, T.-H. Chuang, L. A. Casiano, G. A. O'Brien, P. Fitzgerald, E. M. Tan, G. M. Bokoch, A. H. Greenberg, and D. R. Green. 1996. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/ CED-3 family protease, CPP-32, via a novel two-step mechanism. EMBO J. 15:2407.
10. Gu, Y., C. Samecki, M. A. Fleming, J. A. Lippke, R. C. Bleackley, and M. S-S. Su. 1996. Processing and activation of CMH-1 by Granzyme B. J. Biol. Chem. 271:10816.
11. Fernandcs-Alnemri, T., R. C. Armstrong, J. Krebs, S. M. Srinivasula, L. Wang, F. Bullrich, L. C. Fritz, J. A. Trapani, K. J. Tomaselli, G. Litwack, and E. S. Alnemri. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93:7464.
12. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex, Cell 85:817.
13. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803.
14. Quan, L. T., M. Tewari, K. O'Rourke, V. Dixit, S. J. Snipas, G. G. Poirier, C. Ray, D. J. Pickup, and G. S. Salvesen. 1996. Proteolytic activation of the cell death protease Yama/CPP-32 by granzyme B. Proc. Natl. Acad. Sci. USA 93: 1972.
15. Darmon, A. J., T. J. Ley, D. W. Nicholson, and R. C. Bleakley. 1996. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J. Biol. Chem. 271:21709.
16. Froelich, C. J., K. Orth, J. Turbov, P. Seth, R. Gottlieb, B. Babior, G. M. Shah, R. C. Bleackley, V. M. Dixit, and W. Hanna. 1996. New paradigm for lymphocyte granule-mediated cytotoxicity. J. Biol. Chem. 271:29073.
17. Tewari, M. L. T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesen, and V. M. Dixit. 1995. YAMA/CPP32β, a mammalian homolog of Ced3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801.
18. Hasegawa, J. I., S. Kamada, W. Kamiike, S. Shimizu, T. Imazu, H. Matsuda, and Y. Tsujimoto. 1996. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis: Cancer Res. 56:1713.
19. Greidinger, E. L., D. K. Miller, T.-T. Yamin, L. Casciola-Rosen, and A. Rosen. 1996, Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett. 390:299.
20. Vaux, D. L., S. Cory, and J. M. Adams, 1988. Bcl-2 promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440.
21. Hockenberry, D., G. Nunez, C. Milliman, R. D. Schreiber, and S. J. Korsmeyer. 1990. Bc12 is an inner mitochondrial protein that blocks programmed cell death. Nature 348:334.
22. Reed, J. C. 1994. Bcl-2 and regulation of programmed cell death. J. Cell Biol. 124:1.
23. Boulakia, C. A., G. Chen, F. W. Ng, J. G. Teodora, P. E. Branton, D. W. Nicholson, G. G. Poirier, and G. C. Shore, 1996. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene 12:529.
24. Shimizu, S., Y. Eguchi, W. Kamiike, H. Matsuda, and Y. Tsujimoto. 1996. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 12:2251.
25. Chinnaiyan, A. M., K. Orth, K. O'Rourke, H. Duan, G. G. Poirier, and V. M. Dixit. 1996. Molecular ordering of the cell death pathway. J. Biol. Chem. 271: 4573.
26. Colusish, S. C., S. Green, and P. R. Clarke. 1996. Bcl-2 regulates activation of apoptotic proteases in a cell-free system. Curr. Biol. 6:997.
27. Armstrong, R. C., T. Aja, J. Xiang, S. Gaur, J. F. Krebs, K. Hoang, X. Bai, S. J. Korsmeyer, D. S. Karanewsky, L. C. Fritz, and K. J. Tomaselli. 1996, Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271:16850.
28. Zhivotovsky, B., D. H. Burgess, and S. Orrenius. 1996. Proteases in apoptosis. Experientia 52:968.
29. Vaux, D. L., H. L. Aguila, and I. L. Weissmann. 1992. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell-mediated killing. Int. Immunol. 4:821.
30. Torigoe, T., J. A. Millan, S. Takayama, R. Taichman, T. Miyashita, and J. C. Reed. 1994, Bcl-2 inhibits T cell-mediated cytolysis of a leukemia cell line. Cancer Res. 54:4851.
31. Chiu, V. K., C. M. Walsh, C. C. Liu, J. C. Reed, and W. R. Clarck. 1995. Bcl-2 blocks degradation but not Fas-based-cell-mediated cytotoxicity. J. Immunol. 154:2023.
32. Schröeter, M., B. Lowin, C. Borner, and J. Tschopp. 1995. Regulation of Fas (APO-1/CD95)- and perform-mediated lysis pathways of primary cytotoxic lymphocytes by the proto-oncogene Bcl-2. Eur. J. Immunol. 25:3509.
33. Doherty, P. C. 1993. Cell-mediated cytotoxicity. Cell 75:607.
34. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxic: two pathways and multiple effector molecules. Immunity 1:343.
35. Podack, E. R. 1995. Execution and suicide: cytotoxic lymphocytes enforce draconian laws through separate molecular pathways, Curr. Opin. Immunol. 1:11.
36. Golstein, P. 1995. Fas-based T cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol. 198:25.
37. Roger, R., C. Isaad, M. Pallardy, M. C. Léglise, A. G. Turhan, J. Bertoglio, and J. Bréard. 1996. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells. Blood 87:1113.
38. Fadock, V. A., D. R. Voelker, P. A. Campell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposition of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207.
39. Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczca, M. A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795.
40. Roger, R., J. Bréard, M. Comisso, C. Bohuon, M. Pallardy, and J. Bertoglio. 1996. CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis. Cell. Immunol. 168:24.
41. Simonin, F., J. Menissier de Murcia, O. Poch, S. Muller, G. Gradwohl, M. Molinete, C. Penning, G. Keith, and G. de Murcia. 1990. Expression and site-directed mutagenesis of the catalytic domain of human poly(ADP)-ribose polymerase in Escherichia coli: lysine 893 is critical for activity. J. Biol. Chem. 265:19249.
42. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkcnazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687.
43. Kitson, J., T. Raven, Y.-P, Jiang, D. V. Goeddel, K. M. Giles, K.-T. Pun, C. J. Grinham, R. Brown, and S. N. Farrow. 1996. A death-domain-containing receptor that mediates apoptosis. Nature 384:372.
44. Russell, J. H., V. Masakowski, T. Rucinsky, and G. Phillips. 1982. Mechanisms of immune lysis. III. Characterization of the nature and kinetics of the cytotoxic T lymphocyte-induced nuclear lesion in the target. J. Immunol. 128:2087.
45. Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Laballe, Y. A. Lazebnik, N. A. Munday, S. M. Raju, M. E. Smulson, T. T. Yamin, V. L. Yu, and D. K. Miller. 1995. Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis. Nature 376:37.
46. Froelich, C. J., W. L. Hanna, G. G. Poirier, P. J. Duriez, D. D'Amours, G. S. Salvesen, E. S. Alnemri, W. C. Earnshaw, and G. M. Shah. 1996. Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment. Biochem. Biophys. Res. Commun. 227:658.
47. Soldatenkov, V. A., S. Prasad, V. Notario, and A. Dritschilo. 1995. Radiation-induced apoptosis of Ewing's sarcoma cells: DNA fragmentation and proteolysis of poly(ADP-ribose) polymerase. Cancer Res. 55:4240.
48. Wyllie, A. H., J. F. R. Ken, and A. R. Lurrie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251.
49. Martin, S. J., C. P. M. Reutelingsperger, A. J. McGahon, J. Rafer, R. C. Van Schie, D. M. Laface, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1.
50. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutlingsperger. 1995. A novel assay for apoptosis flow cytometric detection of phosphatidylscrine expression on early apoptotic cells using fluorescein labeled annexin V. J. Immunol. Methods 184:39.
51. Salcedo, T. W., L. Azzoni, S. F. Wolf, and B. Perussia. 1993. Modulation of perform and granzyme messenger RNA expression in human natural killer cells. J. Immunol. 151:2511.
52. Jones, J., M. B. Hallett, and B. P. Morgan. 1990. Reversible cell damage by T-cell performs. Biochem. J. 267:303.
53. Shiver, J. W., L. Su, and P. A. Henkart. 1992. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 71:315.